Denver, CO, United States of America

Margaret E Macy

This inventor holds 1 USPTO granted patent. Top assignee: University of Colorado. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Margaret E Macy. Retrieved from https://idiyas.com/inventor/margaret-e-macy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Leukemia Detection by Margaret E. Macy

Introduction

Margaret E. Macy is a prominent inventor based in Denver, Colorado. She has made significant contributions to the field of medical diagnostics, particularly in the detection of leukemia cells. Her innovative methods have the potential to improve patient outcomes and enhance the understanding of leukemia progression.

Latest Patents

Margaret E. Macy holds a patent for "Methods of leukemia cell detection." This patent outlines various methods for determining the presence of leukemia cells in a subject. It also includes techniques for assessing changes in the number of leukemia cells over time, identifying tissues containing multiple leukemia cells or progenitor leukemia cells, and evaluating the effectiveness of leukemia therapies in reducing cell counts.

Career Highlights

Margaret is affiliated with the University of Colorado, where she conducts her research and develops her innovative methods. Her work has garnered attention for its potential impact on leukemia diagnostics and treatment strategies.

Collaborations

Some of her notable coworkers include Lia Gore and Deborah Deryckere, who contribute to the research efforts in leukemia detection and treatment.

Conclusion

Margaret E. Macy's contributions to leukemia cell detection represent a significant advancement in medical diagnostics. Her innovative methods have the potential to transform how leukemia is diagnosed and treated, ultimately benefiting patients and healthcare providers alike.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…